1. Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition
    Preeyaporn Plaimee Phiboonchaiyanan et al, 2017, Cell Biol Toxicol CrossRef
  2. BAMBI overexpression together with β-sitosterol ameliorates NSCLC via inhibiting autophagy and inactivating TGF-β/Smad2/3 pathway
    Xingchun Wang et al, 2017 CrossRef
  3. Prospects for new lung cancer treatments that target EMT signaling
    Yuji Otsuki et al, 2017, Dev. Dyn. CrossRef
  4. null
    Santanu Maji et al, 2017 CrossRef
  5. Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion
    Adelaide IJ Young et al, 2017, Cell Adhesion & Migration CrossRef
  6. Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview
    Do Kim et al, 2017, JCM CrossRef
  7. PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma
    Qi Liu et al, 2017 CrossRef
  8. The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
    Kazuya Kuwada et al, 2018, J Exp Clin Cancer Res CrossRef
  9. Epithelial-to-mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy.
    Mau Ern Poh et al, 2019, Thorac Cancer CrossRef
  10. ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cell-fibroblast cross-talk involved in NSCLC MultiDrug Resistance
    Dania Movia et al, 2019, BMC Cancer CrossRef
  11. Copy-number variation ofMCL1predicts overall survival of non-small-cell lung cancer in a Southern Chinese population
    Jieyun Yin et al, 2016, Cancer Med CrossRef
  12. MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1
    Dezhi Cheng et al, 2016, Mol Cell Biochem CrossRef
  13. EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation
    Ana Vila et al, 2016, PLoS ONE CrossRef
  14. Inhibition of Non-Small Cell Lung Cancer Cells by Oxy210, an Oxysterol-Derivative that Antagonizes TGFβ and Hedgehog Signaling
    null Stappenbeck et al, 2019, Cells CrossRef
  15. Suitable parameter choice on quantitative morphology of A549 cell in epithelial–mesenchymal transition
    Zhou-Xin Ren et al, 2015 CrossRef
  16. Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes
    Tomas Tokar et al, 2018, Oncotarget CrossRef
  17. Cancer cell‑specific anticancer effects of Coptis�chinensis on gefitinib‑resistant lung cancer cells are mediated through the suppression of Mcl‑1 and Bcl‑2
    Jae Hwan Kim et al, 2020, Int J Oncol CrossRef
  18. Reserpine inhibits DNA repair, cell proliferation, invasion and induces apoptosis in oral carcinogenesis via modulation of TGF-β signaling
    Arunkumar Ramu et al, 2020, Life Sciences CrossRef
  19. Rational Combination Therapy for Melanoma with Dinaciclib by Targeting BAK-Dependent Cell Death.
    Xiaoou Xu et al, 2020, Mol Cancer Ther CrossRef
  20. PAK1 Is a Novel Therapeutic Target in Tyrosine Kinase Inhibitor–Resistant Lung Adenocarcinoma Activated by the PI3K/AKT Signaling Regardless of EGFR Mutation
    De-Wei Wu et al, 2016, Clin Cancer Res CrossRef
  21. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non–Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion
    Sebastian Marwitz et al, 2016, Cancer Res CrossRef
  22. Cancer drug resistance induced by EMT: novel therapeutic strategies
    Javier De Las Rivas et al, 2021, Arch Toxicol CrossRef
  23. PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells
    Tae Woo Kim et al, 2021, Sci Rep CrossRef
  24. Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression
    Leili Hasanifard et al, 2018, Drug Res (Stuttg) CrossRef
  25. Clinical Impact of the Epithelial-Mesenchymal Transition in Lung Cancer as a Biomarker Assisting in Therapeutic Decisions.
    Julien Ancel et al, 2022, Cells Tissues Organs CrossRef
  26. A novel cell-based assay for the high-throughput screening of epithelial–mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial–mesenchymal transition
    Hiroyuki Ishikawa et al, 2022, Lung Cancer CrossRef
  27. Polypeptide antibiotic actinomycin D induces Mcl-1 uncanonical downregulation in lung cancer cell apoptosis
    Chia-Ling Chen et al, 2023, Life Sciences CrossRef
  28. Inhibition of epithelial‐to‐mesenchymal transition augments antitumor efficacy of nanotherapeutics in pancreatic ductal adenocarcinoma
    Kai‐Zhou Jin et al, 2023, The FEBS Journal CrossRef
  29. M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma
    Ryota Sumitomo et al, 2023, Cancer Science CrossRef
  30. MicroRNA-29b-3p reduces cisplatin resistance in non-small cell lung cancer by targeting myeloid cell leukemia-1
    Yuanjun Cheng et al, 2024, Mol. Cell. Toxicol. CrossRef
  31. Desmethylclomipramine triggers mitochondrial damage and death in TGF-β-induced mesenchymal type of A549 cells
    Fu-Chia Shih et al, 2024, Life Sciences CrossRef